Rockwell Medical, Inc.
RMTI
$7.96
-$0.11-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 2.56% | -5.51% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.56% | -5.51% | |||
| Cost of Revenue | 0.68% | -0.20% | |||
| Gross Profit | 11.94% | -25.30% | |||
| SG&A Expenses | -2.58% | 2.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.13% | 0.38% | |||
| Operating Income | 28.31% | -271.86% | |||
| Income Before Tax | 26.98% | -189.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 26.98% | -189.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 26.98% | -189.71% | |||
| EBIT | 28.31% | -271.86% | |||
| EBITDA | 41.28% | -754.73% | |||
| EPS Basic | 17.68% | -189.62% | |||
| Normalized Basic EPS | 24.83% | -169.46% | |||
| EPS Diluted | 17.68% | -170.74% | |||
| Normalized Diluted EPS | 24.83% | -169.46% | |||
| Average Basic Shares Outstanding | 0.43% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.43% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||